Monoclonal Gammopathy of Undetermined Significance (MGUS)

Virtual assistant designed to support hematologists, internists, primary care physicians, nephrologists, neurologists, and nursing staff in the diagnosis, risk stratification, monitoring, and management of MGUS/MGUS complications, based on guidelines and consensus statements (IMWG, ESMO, NCCN) valid until August 2025.

Copied to clipboard

Content automatically generated by an artificial intelligence system.It may contain inaccuracies.